MedTrace Logo

A Teleheath tDCS Approach to Decrease Cannabis Use

NCT05005013 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-06-24

Study results available
· View outcomes & findings →

Summary

The study aims to evaluate the effect of Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) in decreasing distress and cannabis use. 46 participants with Relapse Remitting Multiple Sclerosis (RRMS), Cannabis Use Disorder (CUD) and elevated distress (K10 score of 10-35) will be recruited.

Conditions

Interventions

OTHER

Transcranial Direct Current Stimulation (tDCS)

tDCS is noninvasive brain stimulation device that modulates brain activity by delivering a low-intensity electrical current (2.0 mA) through sponge electrodes placed on the scalp.

OTHER

Sham - Transcranial Direct Current Stimulation (tDCS)

The tDCS device is programmed to mimic active tDCS.

OTHER

Mindfulness

Participants will follow an audio track for guided mindfulness during the stimulation.

Sponsors & Collaborators

Principal Investigators

  • Leigh Charvet, PhD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-13
Primary Completion
2024-02-14
Completion
2024-05-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05005013 on ClinicalTrials.gov